DelveInsight’s “Prefilled Syringes Market Insights, Market Trends, and Market Forecast – 2032” report delivers an in-depth analysis of the rapidly evolving prefilled syringes market. The report offers a comprehensive overview of market dynamics, technological advancements, competitive intelligence, and growth drivers shaping the outlook of prefilled syringes across North America, Europe, Asia-Pacific, and Rest of the World.
To know more about the Prefilled Syringes market outlook, product trends, market dynamics, and growth forecast, Click Here: Prefilled Syringes Market Forecast
Key Highlights from DelveInsight’s Prefilled Syringes Market Report
- The Prefilled Syringes market was valued at USD 12,490.79 million in 2024 and is expected to reach USD 27,993.35 million by 2032.
- Prefilled Syringes Market is expected to grow at a CAGR of 10.73% during the forecast period from 2025 to 2032.
- In May 2025, Samsung Bioepis and Organon announced FDA designated HADLIMA™ (adalimumab-bwwd) autoinjectors and high-concentration prefilled syringe as interchangeable biosimilars to Humira®. Combined with prior approvals, HADLIMA is now interchangeable with all Humira® presentations.
- In March 2025, ANI Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® Gel (repository corticotropin injection USP) in a prefilled syringe format.
- In March 2024, SCHOTT Pharma expanded in the U.S. with a new prefillable syringe manufacturing facility in Wilson, North Carolina with a $371 million investment.
- In May 2024, InvAscent, through India Life Sciences IV (ILSF IV), partnered with Morgan Stanley Private Equity Asia to invest INR 10,000 million in Maiva Pharma, recognized as India’s second-largest pure-play injectables Contract Development and Manufacturing Organization (CDMO). The funds raised were intended to enhance vial, lyophilization, and suspension capacity, as well as to introduce new manufacturing capabilities, including prefilled syringes, cartridges, and bags.
- In March 2024, Mallinckrodt plc. announced that the U.S. FDA approved the Acthar® Gel (repository corticotropin injection) Single-Dose SelfJect™ Injector, a new delivery device for Acthar Gel for patients with chronic and acute inflammatory and autoimmune conditions.
- Key prefilled syringes products are categorized by Product Type (Staked Needle System, Luer Cone System, and Luer Lock System), Material (Glass and Plastic), Type (With Needle and Without Needle), and Distribution Channel (Hospital & Retail Pharmacies and Online Pharmacies).
- Pharmaceutical and medical device companies driving prefilled syringes innovation include BD, NIPRO Pharma, Taisei Kako Co., Ltd, TERUMO PHARMACEUTICAL SOLUTIONS, SCHOTT AG, Gerresheimer AG, West Pharmaceutical Services, Inc., Dali Medical Devices, Stevanato Group, Credence MedSystems, Inc., Baxter, MAEDA INDUSTRY Co., Ltd., MedXL Inc, IRISYS, LLC, Sandoz International GmbH, Pfizer Inc., Vetter, Weigao Group, Fresenius Kabi, Catalent Inc, and others.
- The staked needle system category in the prefilled syringes market is estimated to dominate the prefilled syringes market with a market share of 68.37% in 2024.
- North America is estimated to hold the largest share of 34% in the global prefilled syringes market in 2024, growing at a CAGR of 11.02% during the forecast period from 2025 to 2032.
- Rising prevalence of chronic diseases, increased use of biologics and biosimilars, and the shift toward self-administration are set to transform market dynamics.
- Technological advancements in syringe design, safety-engineered devices, and expansion of vaccination programs continue to drive innovation and adoption.
Learn more about Prefilled Syringes market trends, product innovations, and regional dynamics. Contact to receive a sample @ Prefilled Syringes Market
Prefilled Syringes: An Essential Drug Delivery Innovation
Prefilled syringes are ready-to-use injectable devices that come pre-loaded with a single dose of medication. They are designed to improve dosing accuracy, reduce medication errors, enhance patient safety, and simplify drug administration for both healthcare professionals and patients.
Prefilled syringes play a crucial role in modern healthcare by enabling convenient self-administration of medications at home, reducing preparation time in clinical settings, and minimizing contamination risks. They are widely used for administering biologics, vaccines, insulin, anticoagulants, and other injectable therapies.
The global prefilled syringes market is growing due to the rise in chronic diseases such as diabetes, rheumatoid arthritis, and autoimmune disorders, increased use of biologics and biosimilars, and the adoption of self-administration models. Beyond traditional hospital use, prefilled syringes are also being increasingly adopted in home healthcare and outpatient settings, given their user-friendly design and enhanced safety features.
Market Dynamics: Drivers and Challenges
DelveInsight’s market analysis evaluates the key factors driving growth and the challenges impacting market expansion across major global regions from 2025 to 2032.
Prefilled Syringes Market Drivers
- Rising prevalence of chronic diseases & long-term conditions: Growing global incidence of chronic diseases such as diabetes, rheumatoid arthritis, autoimmune diseases, and cardiovascular conditions increases demand for regular injections. Prefilled syringes offer a convenient, accurate, ready-to-use format for chronic therapies.
- Increasing use of biologics, biosimilars, and injectable therapies: As more biologic drugs (and biosimilars) enter the market, many require parenteral/injectable delivery. Prefilled syringes—because of sterility, dose accuracy, and stability—become the preferred delivery medium for these therapies.
- Shift toward self-administration and home-healthcare delivery models: Patient preference for self-injection (at home or outside hospital settings), especially for chronic conditions, fuels demand for syringe formats that are easy to use, safe, and don’t require medical professional support. Prefilled syringes satisfy those needs.
- Safety, convenience, and reduction of medication errors: Prefilled syringes come pre-measured, pre-sterilized—reducing risk of dosing errors, contamination, overfill waste, and needle-stick injuries. These advantages are attractive to both healthcare providers and patients.
- Expansion of vaccination/immunization programs & growing demand for injectable vaccines/drugs: Prefilled syringes are widely used for vaccines and immunizations—which require mass, rapid, safe, accurate administration—making them standard in large-scale immunization and prophylactic programs.
- Technological advancements in syringe design & materials: Innovations—e.g., dual-chamber syringes (for lyophilized drugs), safety-engineered syringes, improved glass or polymer materials, better compatibility for biologics—enhance usability, drug stability, and open the door to more drug types.
- Growth of healthcare infrastructure & increased access in emerging markets: As emerging economies expand their healthcare systems, there is increased demand for modern, safe, and efficient drug delivery devices. Prefilled syringes benefit from wider adoption in these regions.
- Regulatory and safety trends favoring prefilled devices: Increasing emphasis on patient safety, standardization (to prevent contamination, dosage errors, needle-stick injuries), and regulatory support for safety-engineered devices encourage adoption of prefilled syringes over traditional vial-and-syringe systems.
- Pharmaceutical companies’ and CMOs’ increasing production capacity and investment: Manufacturers scaling up dedicated prefilled-syringe production lines (or captive facilities), to meet demand for biologics and injectable therapies, supports greater supply and accelerates adoption.
- Need for improved efficiency in hospitals and clinical settings: Prefilled syringes reduce preparation time, reduce waste, lower contamination risks, and simplify workflows in hospitals and clinics—making them attractive for institutional procurement and use.
Prefilled Syringes Market Barriers
- Increasing product recalls and failures due to safety issues
- Availability of alternative drug delivery products and systems
- High initial costs associated with manufacturing and fill-finish operations
- Compatibility challenges with certain sensitive biologics
- Regulatory complexities for drug-device combination products
Explore more about Prefilled Syringes Market Dynamics @ Prefilled Syringes Market Dynamics
Market Segmentation and Product Analysis
The prefilled syringes market is segmented by Product Type, Material, Type, Distribution Channel, and Geography to provide detailed insights into market trends and growth opportunities.
Leading Product Categories:
By Product Type:
- Staked Needle System: Dominates the market with a share of 68.37% in 2024. The adoption of staked needle systems is significantly boosting the overall prefilled syringes market by addressing key challenges in drug delivery and enhancing the usability, safety, and efficiency of injectable therapies. The fixed-needle design reduces the risk of needle-stick injuries, ensures precise dosing, and minimizes medication waste.
- Luer Cone System: Offers compatibility with various needle types and provides flexibility in drug delivery applications.
- Luer Lock System: Provides secure needle attachment and is widely used in clinical settings requiring enhanced safety.
By Material:
- Glass Prefilled Syringes: Traditional choice offering chemical stability and compatibility with a wide range of drug formulations.
- Plastic Prefilled Syringes: Growing adoption due to lightweight design, reduced breakage risk, and suitability for certain biologics. Cyclic olefin polymer (COP) syringes represent an emerging technology segment.
By Type:
- With Needle: Integrated needle systems for immediate use
- Without Needle: Requires separate needle attachment, offering flexibility
By Distribution Channel:
- Hospital & Retail Pharmacies: Primary distribution channel for institutional and outpatient use
- Online Pharmacies: Emerging channel supporting home healthcare and patient convenience
Regional Market Analysis
North America: Market Leader
North America is estimated to hold the largest share of 34% in the global prefilled syringes market in 2024, growing at a CAGR of 11.02% during the forecast period from 2025 to 2032.
Key Drivers in North America:
- High prevalence of chronic diseases: According to the Centers for Disease Control and Prevention (CDC) in 2023, around 53.2 million people (21.2%) had been diagnosed with arthritis and rheumatoid arthritis in the United States between 2019 to 2021. Additionally, around 38.4 million people, accounting for 11.6% of the US population, were suffering from diabetes in 2021.
- Strong adoption of biologics and biosimilars: The use of biologics and biosimilars for complex conditions like cancer and autoimmune diseases has driven demand for user-friendly injection systems.
- Well-established patient care system: High awareness among patients and caregivers regarding different types of prefilled syringes supports market growth.
- Technological innovation: Rapid adoption of technologically advanced solutions, including autoinjectors and smart delivery systems.
- Strategic company activities: Increasing product launches, regulatory approvals, and facility expansions by key market players.
Europe: Steady Growth Market
Europe represents a significant market driven by aging populations, universal healthcare coverage, and strong regulatory frameworks supporting safe drug delivery systems.
Asia-Pacific: Fastest Growing Market
Asia-Pacific is emerging as the fastest-growing region due to expanding healthcare infrastructure, rising chronic disease burden, increasing biologics adoption, and growing pharmaceutical manufacturing capabilities in countries like China, India, Japan, and South Korea.
Prefilled Syringes Competitive Landscape
The prefilled syringes market features intense competition among established medical device manufacturers, pharmaceutical companies, and emerging innovators focused on advanced drug delivery systems.
Key Prefilled Syringes Companies:
- BD – Leading manufacturer of prefilled syringes and drug delivery systems
- NIPRO Pharma – Comprehensive injectable drug delivery solutions
- Taisei Kako Co., Ltd – Specialized prefilled syringe manufacturer
- TERUMO PHARMACEUTICAL SOLUTIONS – Advanced drug delivery technologies
- SCHOTT AG – Premium glass syringe systems
- Gerresheimer AG – Glass and plastic primary packaging for pharmaceuticals
- West Pharmaceutical Services, Inc. – Containment and delivery systems
- Dali Medical Devices – Innovative syringe technologies
- Stevanato Group – Integrated drug delivery solutions
- Credence MedSystems, Inc. – Safety-engineered injection systems
- Baxter – Comprehensive healthcare solutions
- MAEDA INDUSTRY Co., Ltd. – Precision medical devices
- MedXL Inc – Advanced delivery systems
- IRISYS, LLC – Specialty medical devices
- Sandoz International GmbH – Biosimilars and prefilled delivery systems
- Pfizer Inc. – Pharmaceutical manufacturer with integrated delivery solutions
- Vetter – Contract manufacturing and fill-finish services
- Weigao Group – Medical device manufacturer
- Fresenius Kabi – Injectable pharmaceuticals and delivery systems
- Catalent Inc – Drug development and manufacturing services
These organizations are actively pursuing strategic collaborations, facility expansions, acquisitions, and technological innovations to strengthen their market positioning.
Scope of the Prefilled Syringes Market Report
DelveInsight’s Prefilled Syringes Market Insights, Market Trends, and Market Forecast – 2032 includes:
- Study Period: 2022-2032
- Forecast Period: 2025-2032
- Geographic Coverage: North America, Europe, Asia-Pacific, and Rest of the World
- Market Assessment: Comprehensive market sizing, segmentation analysis, and growth projections
- Product Analysis: Detailed evaluation of product types, materials, and distribution channels
- Market Dynamics: Comprehensive evaluation of growth drivers, barriers, opportunities, and competitive insights
- Analytical Frameworks: SWOT analysis, PESTLE analysis, Porter’s five forces, and market entry strategies
- Technology Trends: Assessment of emerging technologies including smart syringes, polymer innovations, and safety-engineered systems
- Regulatory Landscape: Analysis of FDA, EMA, and regional regulatory requirements
- Competitive Intelligence: Company profiles, product portfolios, strategic initiatives, and market positioning
- Recent Developments: Product launches, regulatory approvals, partnerships, acquisitions, and facility expansions
Table of Contents
- Prefilled Syringes Market Report Introduction
- Prefilled Syringes Market Executive Summary
- Prefilled Syringes Competitive Landscape
- Prefilled Syringes Regulatory Analysis
- Prefilled Syringes Market Key Factors Analysis
- Prefilled Syringes Market Porter’s Five Forces Analysis
- Prefilled Syringes Market Assessment
- Prefilled Syringes Market Company and Product Profiles
- Prefilled Syringes KOL Views
- Project Approach
- About DelveInsight
- Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
kkumar@delveinsight.com
